Paul Cronin

Paul Cronin is an experienced professional in the pharmaceutical and biotechnology industry, currently serving as the Director at Scendea since May 2020. Prior to this role, Paul was the Director at Clinical Network Services until its rebranding to Scendea in June 2020 and also contributed as an Advisory Board Member at BioPartner UK from April 2019 to August 2021. Previous positions include Director of Business Development at Diamond Pharma Services and Business Development Manager at Smerud Medical Research, along with a notable tenure at ERA Consulting (UK) Ltd. Paul has editorial experience as a Consultant Editor for the TOPRA journal, Regulatory Rapporteur. Paul holds an MSc in International Business and Management from Alliance Manchester Business School and a BSc in Biochemistry from The University of Manchester.